Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma
Acta Dermato-Venereologica · 07.02.2023 · 103 · adv00860
DOI: 10.2340/actadv.v103.3209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Dermato-Venereologica, online erschienen am 07.02.2023. Verfasst von Kalle Mattila und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and FICAN West Cancer Centre, Turku University Hospital and University of Turku, Turku, Finland; InFLAMES Research Flagship Ce…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Previous studies have suggested that persistent tobacco smoking impairs survival in cutaneous melanoma, but the effects of smoking and other prognostic factors have not been described in detail. This study examined the association of smoking (persistent, former, or never) with melanoma-specific (MSS) and overall survival (OS) in patients with cutaneous melanoma treated in Southwest Finland during 2005 to 2019. Clinical characteristics were obtained from electronic health records for 1,980 patients. Smoking status was available for 1,359 patients. Patients were restaged according to the 8th edition of the tumour-node-metastasis (TNM) classification. Smoking remained an independent prognostic factor for inferior melanoma-specific survival regardless of age, sex, stage, and comorbidities. The hazard ratio of death from melanoma was 1.81 (1.27−2.58, p = 0.001) in persistent and 1.75 (1.28−2.40, p = 0.001) in former smokers compared with never smokers. In 351 stage IV patients, smoking was associated with increased melanoma-specific and overall mortality: median MSS 10.4 (6.5−14.3), 14.6 (9.1−20.1), and 14.9 (11.4−18.4) months, p = 0.01 and median OS 10.4 (6.5−14.3), 13.9 (8.6−19.2), and 14.9 (11.7−18.1) months, p = 0.01 in persistent, former, and never smokers, respectively. In conclusion, since smoking represents an independent modifiable poor prognostic factor in patients with cutaneous melanoma, smoking habits should be proactively asked about by healthcare professionals, in order to support smoking cessation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Oncology and FICAN West Cancer Centre, Turku University Hospital and University of Turku, Turku, Finland; InFLAMES Research Flagship Center, University of Turku, Turku, Finland.
- Turku School of Economics, University of Turku, Turku, Finland.
- Auria Biobank and Turku University Hospital, Turku Finland.
- Department of Oncology and FICAN West Cancer Centre, Turku University Hospital and University of Turku, Turku, Finland.
- Department of Oncology and FICAN West Cancer Centre, Turku University Hospital and University of Turku, Turku, Finland. eetu.heerva@tyks.fi.
Zitieren
APA
Mattila, K., Vihinen, H., Karlsson, A., Minn, H., Vihinen, P., & Heervä, E. (2023). Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma. Acta Dermato-Venereologica, 103, adv00860. https://doi.org/10.2340/actadv.v103.3209
Vancouver
Mattila K, Vihinen H, Karlsson A, Minn H, Vihinen P, Heervä E. Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma. Acta Dermato-Venereologica. 2023;103:adv00860. doi:10.2340/actadv.v103.3209
BibTeX
@article{Mattila2023,
author = {Mattila, Kalle and Vihinen, Helmi and Karlsson, Antti and Minn, Heikki and Vihinen, Pia and Heervä, Eetu},
title = {Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma},
journal = {Acta Dermato-Venereologica},
year = {2023},
volume = {103},
pages = {adv00860},
doi = {10.2340/actadv.v103.3209}
}
EUVIMED